Also known as BAY 59-7939, BAY59-7939, Xarelto An orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon oral administration, rivaroxaban selectively binds to both free factor Xa and factor Xa...
See full medical information
# Thrombocytopenia
Clinical trials for drug safety evaluation, please follow the links below to make smart and accurate drug decisions.
Info about medications while breastfeeding